Takeda will refocus R&D on three targeted therapeutic areas – oncology, gastroenterology and CNS. Vaccines will also continue to play an important role.
- Celgene Snaps Up Merck & Co.’s Giant Complex in New Jersey 7,500 views
- Top 10 Pipelines 5,766 views
- Annual Report: Top 10 Pipelines 4,700 views
- Top 100 Biotechnology Companies Special Report: The Acquisition Game 2,700 views